Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis

J Allergy Clin Immunol. 2017 Mar;139(3):1065. doi: 10.1016/j.jaci.2016.08.023. Epub 2016 Oct 26.

Authors

Judith L Thijs¹, Athula Herath², Marjolein S de Bruin-Weller¹, DirkJan Hijnen³

Affiliations

¹ Department of Dermatology and Allergology, University Medical Center Utrecht, The Netherlands.
² Novartis Pharmaceuticals, East Hanover, NJ.
³ Department of Dermatology and Allergology, University Medical Center Utrecht, The Netherlands. Electronic address: [email protected].

PMID: 28341480
DOI: 10.1016/j.jaci.2016.08.023

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Blood Proteins
Computational Biology*
Dermatitis, Atopic*
Eczema
Humans

Substances

Biomarkers
Blood Proteins